Clinical Trial Update: Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study

View source ↗

Summary

A completed prospective multicenter study in high-risk Non-Hodgkin's Lymphoma patients treated with 3-weekly CHOP-like chemotherapy and primary G-CSF prophylaxi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Yonsei University | Conditions: Non-Hodgkin's Lymphoma | Status: COMPLETED